The Hough Ear Institute is ready for Phase II clinical trials for the first ever FDA approved treatment for tinnitus.

The last step before this pill goes into Phase II clinical trials for tinnitus is to run a proof of concept study to ensure that the pill’s effect on tinnitus can be objectively measured. To learn more, click here.

If you would like to receive updates about this novel approach to treat tinnitus and the mission of the Hough Ear Institute, sign up here! You will receive a quarterly newsletter, updates on our mission and the amazing research done by our team, and most of all – the opportunity to be a part of the solution, advancing new treatments and cures for acquired hearing loss and tinnitus.